{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:37:51Z","timestamp":1767915471367,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81970682"],"award-info":[{"award-number":["81970682"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81700697"],"award-info":[{"award-number":["81700697"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72374007"],"award-info":[{"award-number":["72374007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02463-7","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T05:01:47Z","timestamp":1728882107000},"page":"419-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of acarbose and metformin on thyroid function and thyroid hormone sensitivity in type 2 diabetes patients: a post-hoc analysis of the MARCH study"],"prefix":"10.1007","volume":"48","author":[{"given":"Chenyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-2380","authenticated-orcid":false,"given":"Zhongyan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"7","key":"2463_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","volume":"12","author":"P Perros","year":"1995","unstructured":"Perros P, McCrimmon RJ, Shaw G, Frier BM (1995) Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 12(7):622\u2013627 Epub 1995\/07\/01. https:\/\/doi.org\/10.1111\/j.1464-5491.1995.tb00553.x","journal-title":"Diabet Med"},{"issue":"4","key":"2463_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2265.2005.02246.x","volume":"62","author":"SA Chubb","year":"2005","unstructured":"Chubb SA, Davis WA, Inman Z, Davis TM (2005) Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol (Oxf) 62(4):480\u2013486 Epub 2005\/04\/06. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02246.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2463_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1758-5996-5-58","volume":"5","author":"CC Palma","year":"2013","unstructured":"Palma CC, Pavesi M, Nogueira VG, Clemente EL, Vasconcellos Mde F, Pereira LCJ et al (2013) Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetol Metab Syndr 5(1):58 Epub 2014\/02\/07. https:\/\/doi.org\/10.1186\/1758-5996-5-58","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2463_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/jc.2005-1210","volume":"91","author":"RA Vigersky","year":"2006","unstructured":"Vigersky RA, Filmore-Nassar A, Glass AR (2006) Thyrotropin suppression by metformin. J Clin Endocrinol Metab 91(1):225\u2013227 Epub 2005\/10\/13. https:\/\/doi.org\/10.1210\/jc.2005-1210","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2463_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12020-007-9012-3","volume":"32","author":"ML Isidro","year":"2007","unstructured":"Isidro ML, Pen\u00edn MA, Nemi\u00f1a R, Cordido F (2007) Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 32(1):79\u201382 Epub 2007\/11\/10. https:\/\/doi.org\/10.1007\/s12020-007-9012-3","journal-title":"Endocrine"},{"issue":"1","key":"2463_CR6","doi-asserted-by":"publisher","first-page":"E143","DOI":"10.1210\/jc.2013-2965","volume":"99","author":"R Lupoli","year":"2014","unstructured":"Lupoli R, Di Minno A, Tortora A, Ambrosino P, Lupoli GA, Di Minno MN (2014) Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J Clin Endocrinol Metab 99(1):E143\u2013E148. https:\/\/doi.org\/10.1210\/jc.2013-2965. Epub 2013\/11\/10","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2463_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/s2213-8587(13)70021-4","volume":"2","author":"W Yang","year":"2014","unstructured":"Yang W, Liu J, Shan Z, Tian H, Zhou Z, Ji Q et al (2014) Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol 2(1):46\u201355 Epub 2014\/03\/14. https:\/\/doi.org\/10.1016\/s2213-8587(13)70021-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2463_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2265.2012.04468.x","volume":"78","author":"JJ D\u00edez","year":"2013","unstructured":"D\u00edez JJ, Iglesias P (2013) Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin Endocrinol (Oxf) 78(4):505\u2013511 Epub 2012\/06\/13. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04468.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2463_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4149\/bll_2016_084","volume":"117","author":"D Dimic","year":"2016","unstructured":"Dimic D, Golubovic MV, Radenkovic S, Radojkovic D, Pesic M (2016) The effect of metformin on TSH levels in euthyroid and hypothyroid newly diagnosed diabetes mellitus type 2 patients. Bratisl Lek Listy 117(8):433\u2013435 Epub 2016\/08\/23. https:\/\/doi.org\/10.4149\/bll_2016_084","journal-title":"Bratisl Lek Listy"},{"issue":"3","key":"2463_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2265.2011.04042.x","volume":"75","author":"M Rotondi","year":"2011","unstructured":"Rotondi M, Cappelli C, Magri F, Botta R, Dionisio R, Iacobello C et al (2011) Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf) 75(3):378\u2013381 Epub 2011\/04\/28. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04042.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2463_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2337\/dc18-1410","volume":"42","author":"M Laclaustra","year":"2019","unstructured":"Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, Casasnovas JA, Guallar-Castillon P et al (2019) Impaired sensitivity to thyroid hormones is Associated with Diabetes and metabolic syndrome. Diabetes Care 42(2):303\u2013310 Epub 2018\/12\/16. https:\/\/doi.org\/10.2337\/dc18-1410","journal-title":"Diabetes Care"},{"issue":"4","key":"2463_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/thy.2021.0500","volume":"32","author":"Y Sun","year":"2022","unstructured":"Sun Y, Teng D, Zhao L, Shi X, Li Y, Shan Z et al (2022) Impaired sensitivity to thyroid hormones is Associated with Hyperuricemia, obesity, and Cardiovascular Disease risk in subjects with subclinical hypothyroidism. Thyroid 32(4):376\u2013384 Epub 2022\/01\/27. https:\/\/doi.org\/10.1089\/thy.2021.0500","journal-title":"Thyroid"},{"issue":"1","key":"2463_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12967-023-04276-3","volume":"21","author":"Z Wu","year":"2023","unstructured":"Wu Z, Jiang Y, Li P, Wang Y, Zhang H, Li Z et al (2023) Association of impaired sensitivity to thyroid hormones with hyperuricemia through obesity in the euthyroid population. J Transl Med 21(1):436 Epub 2023\/07\/05. https:\/\/doi.org\/10.1186\/s12967-023-04276-3","journal-title":"J Transl Med"},{"issue":"1","key":"2463_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12020-017-1462-7","volume":"59","author":"M Dornelles Severo","year":"2018","unstructured":"Dornelles Severo M, St\u00fcrmer Andrade T, Correa Junior V, Antonio Naujorks A, Gus M, Schaan BD (2018) Metformin effect on TSH in subclinical hypothyroidism: randomized, double-blind, placebo-controlled clinical trial. Endocrine 59(1):66\u201371 Epub 2017\/10\/29. https:\/\/doi.org\/10.1007\/s12020-017-1462-7","journal-title":"Endocrine"},{"issue":"12","key":"2463_CR15","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s40618-019-01059-w","volume":"42","author":"R Palui","year":"2019","unstructured":"Palui R, Sahoo J, Kamalanathan S, Kar SS, Sridharan K, Durgia H et al (2019) Effect of metformin on thyroid function tests in patients with subclinical hypothyroidism: an open-label randomised controlled trial. J Endocrinol Invest 42(12):1451\u20131458 Epub 2019\/05\/28. https:\/\/doi.org\/10.1007\/s40618-019-01059-w","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2463_CR16","doi-asserted-by":"publisher","first-page":"e1920745","DOI":"10.1001\/jamanetworkopen.2019.20745","volume":"3","author":"K Inoue","year":"2020","unstructured":"Inoue K, Ritz B, Brent GA, Ebrahimi R, Rhee CM, Leung AM (2020) Association of Subclinical Hypothyroidism and Cardiovascular Disease with Mortality. JAMA Netw Open 3(2):e1920745 Epub 2020\/02\/08. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20745","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2463_CR17","doi-asserted-by":"publisher","first-page":"e13349","DOI":"10.1111\/eci.13349","volume":"50","author":"RA Hoshi","year":"2020","unstructured":"Hoshi RA, Santos IS, Dantas EM, Andre\u00e3o RV, Mill JG, Duncan BB et al (2020) Diabetes and subclinical hypothyroidism on heart rate variability. Eur J Clin Invest 50(12):e13349 Epub 2020\/07\/13. https:\/\/doi.org\/10.1111\/eci.13349","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2463_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40618-016-0560-3","volume":"40","author":"N Mansournia","year":"2017","unstructured":"Mansournia N, Riyahi S, Tofangchiha S, Mansournia MA, Riahi M, Heidari Z et al (2017) Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes. J Endocrinol Invest 40(3):289\u2013295 Epub 2016\/10\/16. https:\/\/doi.org\/10.1007\/s40618-016-0560-3","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2463_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.14310\/horm.2002.1559","volume":"14","author":"S Santos-Palacios","year":"2015","unstructured":"Santos-Palacios S, Brugos-Larumbe A, Guill\u00e9n-Grima F, Garmendia-Madariaga A, Galofr\u00e9 JC (2015) Does metformin have a buffer effect on serum TSH levels in euthyroid diabetic patients? Horm (Athens) 14(2):280\u2013285 Epub 2015\/01\/03. https:\/\/doi.org\/10.14310\/horm.2002.1559","journal-title":"Horm (Athens)"},{"issue":"2","key":"2463_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1530\/eje-12-0225","volume":"167","author":"C Cappelli","year":"2012","unstructured":"Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti A, Zarra E et al (2012) Thyreotropin levels in diabetic patients on metformin treatment. Eur J Endocrinol 167(2):261\u2013265 Epub 2012\/05\/31. https:\/\/doi.org\/10.1530\/eje-12-0225","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2463_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/bf03401339","volume":"13","author":"C Cappelli","year":"2014","unstructured":"Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti AM, De Cata P et al (2014) Metformin-induced thyrotropin suppression is not associated with cardiac effects. Horm (Athens) 13(2):252\u2013258 Epub 2014\/04\/30. https:\/\/doi.org\/10.1007\/bf03401339","journal-title":"Horm (Athens)"},{"key":"2463_CR22","doi-asserted-by":"publisher","unstructured":"Tee SA, Tsatlidis V, Razvi S (2023) The GLP-1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes. Clin Endocrinol (Oxf). Epub 2023\/02\/28. https:\/\/doi.org\/10.1111\/cen.14901","DOI":"10.1111\/cen.14901"},{"issue":"7","key":"2463_CR23","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s40618-020-01445-9","volume":"44","author":"R Cannarella","year":"2021","unstructured":"Cannarella R, Condorelli RA, Barbagallo F, Aversa A, Calogero AE, La Vignera S (2021) TSH lowering effects of metformin: a possible mechanism of action. J Endocrinol Invest 44(7):1547\u20131550 Epub 2020\/10\/16. https:\/\/doi.org\/10.1007\/s40618-020-01445-9","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2463_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2265.2011.04058.x","volume":"75","author":"R Krysiak","year":"2011","unstructured":"Krysiak R, Okopien B (2011) Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone. Clin Endocrinol (Oxf) 75(3):404\u2013406 Epub 2011\/04\/28. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04058.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2463_CR25","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-Borrego MC, Fuentes-Fayos AC, Gahete MD, Casta\u00f1o JP, Kineman RD, Luque RM (2018) The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-human Primates: a potential path to Expand and integrate its metabolic actions. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 49(4):1444\u20131459 Epub 2018\/09\/12. https:\/\/doi.org\/10.1159\/000493448","DOI":"10.1159\/000493448"},{"issue":"2","key":"2463_CR26","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1530\/ec-19-0482","volume":"9","author":"G Tulipano","year":"2020","unstructured":"Tulipano G (2020) How treatments with endocrine and metabolic drugs influence pituitary cell function. Endocr Connections 9(2):R14\u2013r27 Epub 2020\/01\/07. https:\/\/doi.org\/10.1530\/ec-19-0482","journal-title":"Endocr Connections"},{"key":"2463_CR27","doi-asserted-by":"publisher","first-page":"940633","DOI":"10.3389\/fendo.2022.940633","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Z, Yang T, Li L, Yu L, Liu F et al (2022) Impaired sensitivity to thyroid hormones and carotid plaque in patients with coronary heart disease: a RCSCD-TCM study in China. Front Endocrinol (Lausanne) 13:940633 Epub 2022\/10\/15. https:\/\/doi.org\/10.3389\/fendo.2022.940633","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2463_CR28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1530\/ec-21-0218","volume":"10","author":"M Kert\u00e9sz","year":"2021","unstructured":"Kert\u00e9sz M, Kun S, S\u00e9lley E, Nagy Z, K\u0151szegi T, Wittmann I (2021) A breakthrough-like effect of metformin reduces peripheral resistance to triiodothyronine in euthyroid, non-insulin-resistant, type 2 diabetic patients. Endocr Connections 10(7):782\u2013788 Epub 2021\/06\/18. https:\/\/doi.org\/10.1530\/ec-21-0218","journal-title":"Endocr Connections"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02463-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T14:41:40Z","timestamp":1738334500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02463-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["2463"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02463-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from every patient, and ethical approval was granted by the ethics committees at each clinical site in multiple centres. The study was conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior presentation"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}